ArticleJNCI cancer spectrum2025
Meat consumption and risk of hepatobiliary cancers in the National Institutes of Health-AARP Diet and Health Study.
Article in JNCI cancer spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative transcriptomic analysis reveals miR-26a-5p downregulation and a potential predictive gene signature for the progression of metabolic liver disease.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundWe investigated the relationship between intakes of red, white, and processed meats with liver cancer-including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, gallbladder cancer, and other biliary tract cancers.
methodsThe analytic cohort consisted of 480 347 US adults in the prospective National Institutes of Health-AARP Diet and Health Study who were cancer-free at baseline at ages 50-71 years. With a median follow-up of 19.68 years, we identified 1150 participants with incident liver cancer (219 intrahepatic cholangiocarcinomas and 931 hepatocellular carcinomas), 231 with incident gallbladder cancer, and 472 with other incident biliary tract cancers (272 extrahepatic cholangiocarcinomas). At baseline, a self-administered food frequency questionnaire assessed usual dietary intake. We used multivariable Cox proportional hazards models to estimate the associations of meat type with hepatobiliary cancers. We used substitution models with the "leave-one-out" approach as our primary analysis and addition models as a supplemental analysis.
resultsReplacing red meat with white meat was inversely associated with liver cancer (hazard ratio [HR]50 g/1000 kcal = 0.62, 95% CI = 0.51 to 0.77), hepatocellular carcinoma (HR50 g/1000 kcal = 0.63, 95% CI = 0.50 to 0.80), and intrahepatic cholangiocarcinoma (HR50 g/1000 kcal = 0.56, 95% CI = 0.35 to 0.90). Because of the symmetry of substitution models, replacing white meat with red meat yielded hazard ratios equal to the reciprocal of these values, indicating increased risk for the same cancer sites. No associations were observed for meat intake and gallbladder or other biliary tract cancers.
conclusionsOur study indicates replacing intake of red meat with white meat could lower risk of liver cancer by nearly 40%, whereas replacing white meat with red meat could increase the risk by more than 60%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.